Looker Benjamin 4
4 · Esperion Therapeutics, Inc. · Filed Sep 18, 2025
Insider Transaction Report
Form 4
Looker Benjamin
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-09-17$2.80/sh−6,267$17,573→ 393,670 total
Footnotes (1)
- [F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.